During the past decade, Portneuf Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 9 clinical trials were completed, i.e. on average, 450% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Portneuf Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "Pfizer" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "Puma Biotechnology, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Portneuf Medical Center" #1 collaborator was "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator and "North Central Cancer Treatment Group" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Portneuf Medical Center" are "Recurrent Breast Carcinoma" (3 trials), "Progesterone Receptor Positive" (2 trials), "Respiratory Tract Infection" (2 trials), "Stage IA Breast Cancer AJCC v7" (2 trials) and "Stage IB Breast Cancer AJCC v7" (2 trials). Many other conditions were trialed in "Portneuf Medical Center" in a lesser frequency.

Most popular intervention types in "Portneuf Medical Center" are "Drug" (9 trials), "Other" (8 trials), "Biological" (6 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "Placebo" (4 trials), "Bevacizumab" (3 trials), "Quality-of-Life Assessment" (3 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Portneuf Medical Center" are 6 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Portneuf Medical Center". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Portneuf Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Portneuf Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Portneuf Medical Center has several departments that took part in Clinical trials: "Portneuf Cancer Center at Portneuf Medical Center" - 2 trials